Search Results for: Other News to Note
-
Other News To Note
T3D expects to reposition DB959 as a central nervous system therapy, using its neuroprotective potential to address multiple Alzheimer's disease pathologies, including neuroinflammation, neuronal cell loss, neurotransmitter deficits, tau neurofibrillary tangles and insulin resistance/lowered cerebral glucose metabolism...commercial rights to Bionect (hyaluronic acid sodium salt, 0.2 percent) in oncology markets from Innocutis Holdings LLC to concentrate on niche products for oncology and oncology -
Other News To Note
In other news, Celgene said the European Commission amended the marketing authorization application for Revlimid (lenalidomide) so that it is now approved to treat patients with transfusion-dependent anemia due to low or intermediate-1 risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate -
Other News To Note
The €6 million (US$8 million) grant was provided to the Cardimmun consortium, consisting of Athera, Leiden University Medical Center, Turku PET Center, Clinical Trial Consultants and Smerud Medical Research...Celgene International Sarl, of Boudry, Switzerland, a unit of Celgene Corp., said the European Commission amended the marketing authorization application for Revlimid (lenalidomide) so that it is now approved to treat patients with transfusion-dependent anemia due to low or intermediate-1 risk -
Other News To Note
Aphios Corp., of Woburn, Mass., said it entered joint research collaboration and commercialization agreements with Vivacell Biotechnology Espana SL, of Cordoba, Spain, to develop therapeutics for multiple sclerosis and other neurodegenerative diseases of the central nervous system...Specifically, the partnership will focus on clinical trials to test combinations of immunotherapies, including two investigational drugs from Immune Design's pipeline...That is in contrast to some other antibiotics, such -
Other News To Note
In other news, Biolinerx said it signed an out-licensing agreement with Jiagsu chia-tai Tianqing Pharmaceutical Co...Proceeds will be used to fund clinical trials, R&D for additional alpha-1 antitrypsin (AAT) indications, expanding distribution capabilities for additional territories for marketing AAT product Glassia and for general corporate purposes -
Other News To Note
according to the protocol, all patients were to have been treated with both bortezomib and lenalidomide prior to study entry...Based on the positive results GSK said it is planning to make regulatory submissions in Europe, the U.S., as well as other regions during the next few -
Other News To Note
If approved, Lojuxta will be indicated as an adjunct to a low-fat diet and other lipid-lowering medicinal products with or without low density lipoprotein (LDL) apheresis in adult patients with homozygous familial hypercholesterolemia (HoFH...according to the protocol, all patients were to have been treated with both bortezomib and lenalidomide prior to study entry -
Other News To Note
Additional funding of up to €9 million is anticipated in the following three years...In other news, Elan priced its offering of $850 million aggregate principal amount of 6.25 percent senior notes due 2021 by its wholly owned subsidiaries, Elan Finance public limited co -
Other News To Note
The clinical trial is anticipated to begin in late 2015 -
Other News To Note
Baxter said it will introduce HyQvia in select countries during 2013 and plans to expand the launch to other EU countries in 2014...The program is expected to move into clinical trials within two years -
Other News To Note
Pursuant to the agreement, the company may from time to time sell up to a maximum of $20 million of the company's American Depositary Shares (ADSs...Proceeds would be used to fund clinical trials, R&D for additional alpha-1 antitrypsin (AAT) indications, expanding distribution capabilities for additional territories for marketing AAT product Glassia and for general corporate purposes -
Other News To Note
to produce and supply 123I-labeled NAV5001 for Navidea's late-phase clinical trials...NAV5001, manage the logistics and make arrangements for shipment of NAV5001 to third-party clinical trial sites on behalf of Navidea -
Pharma: Other News To Note
Approval was supported by data from the Program of Ulcerative Colitis Research Studies Utilizing an Investigational Treatment (PURSUIT) clinical trials, evaluating patients with moderately to severely active UC who had previously failed or were intolerant to conventional treatments...The company plans to use proceeds to repurchase common stock and for general corporate purposes, including the repayment of outstanding commercial paper borrowings and upcoming debt maturities -
Pharma: Other News To Note
Under the agreement, Quintiles will direct clinical trial planning and execution of trials guided by Merck Serono's strategy...Quintiles will also contribute to Merck Serono's future trial design process -
Other News To Note
filings, Merck's Canadian subsidiary transferred sponsorship of all vernakalant clinical trial applications to Cardiome...In separate news, Hyperion said it exercised its option to acquire Buphenyl (sodium phenylbutyrate) tablets and powder, an FDA-approved therapy for the chronic management of the most prevalent UCDs, and Ammonul (sodium phenylacetate and sodium benzoate) injection, a hospital-based product used to treat UCD patients in hyperammonemic crisis, from Valeant Pharmaceuticals -
Other News To Note
Addex Therapeutics SA, of Geneva, said regulatory authorities in the Netherlands gave approval to start in the first half of this year a Phase I study of ADX71441, a GABA-B receptor positive allosteric modulator, for Charcot-Marie-Tooth1A (CMT1A) neuropathy and other disease indications...Bionomics Ltd., of Adelaide, South Australia, initiated manufacturing activities at Lonza Group Ltd.'s facility in Slough, UK, to enter BNC101 into clinical trials following completion of key preclinical studies -
Pharma: Other News To Note
Ltd., of Tokyo, entered a clinical trial agreement under which Daiichi will support and co-sponsor a Phase I study of PER977 to reverse the anticoagulant activity of edoxaban...It does not bind to blood coagulation factors or other blood proteins -
Other News To Note
Addex Therapeutics, of Geneva, said regulatory authorities in the Netherlands gave approval to start in the first half of this year a Phase I study of ADX71441, a GABA-B receptor positive allosteric modulator, for Charcot-Marie-Tooth1A (CMT1A) neuropathy and other disease indications...TheraCoat Inc., of Ra'anana, Israel, completed a safety and tolerability study and plans to commence efficacy clinical trials in two bladder indications -
Other News To Note
In separate news, another Galapagos unit, Argenta, inked a deal with Boehringer Ingelheim GmbH, of Ingelheim, Germany, to apply its respiratory drug discovery services to an undisclosed target within Boehringer's respiratory disease portfolio...In other news, BioInvent said the first patient has been treated in a Phase II study of BI-505 for smoldering multiple myeloma, or asymptomatic myeloma -
Other News To Note
for the Brisbane, Australia-based company's Diversity Scanning Array (DSA) and Versatile Assembly on Stable Templates (VAST) technologies in a deal worth up to $240 million in milestones, plus other payments...Bionomics Ltd., of Adelaide, South Australia, initiated manufacturing activities at Lonza Group Ltd.'s facility in Slough, UK, to enter BNC101 into clinical trials following completion of key preclinical studies
Category
Current Filters
- xclinical trials
Related Keywords
Categories
- x BioWorld Today (2094)
- x BioWorld International (422)
- x BioWorld Insight (19)
- x Bio Perspectives (11)
- x State of the Industry Report (8)
- x Top 25 Drug Report (2)
- x BioWorld Snapshots (1)